FindMyRecallSubscribe
Class I: serious health riskTerminated

Pfizer Propofol Injectable Emulsion Recall

Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass flipt…

Pfizer Inc. · New York, NY

Risk level
Class I
Reported by FDA
Aug 3, 2022
Recall ID
D-1301-2022
Check your lot numberHow we source this data

Summary

Pfizer recalled Propofol Injectable Emulsion starting Jul 13, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-1301-2022 on Aug 3, 2022. Reason: Presence of particulate matter: particulate identified as a beetle. Status: Terminated.

Why it was recalled

Presence of particulate matter: particulate identified as a beetle.

Product description

Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Lot numbers, UPCs & expiration codes

Lot #: DX9067, Exp 5/1/2023

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1301-2022
Classification
Class I
Status
Terminated
Recall initiated
Jul 13, 2022
FDA report date
Aug 3, 2022
Quantity
54,000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1301-2022, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
90581
Address
235 East 42nd Street
Code information
Lot #: DX9067, Exp 5/1/2023
Postal code
10017-5703
Report date
Aug 3, 2022
Product type
Drugs
Recall number
D-1301-2022
Classification
Class I
Recalling firm
Pfizer Inc.
Product quantity
54,000 vials
Termination date
May 13, 2024
Reason for recall
Presence of particulate matter: particulate identified as a beetle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Distribution pattern
USA Nationwide
Recall initiation date
Jul 13, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 3, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1301-2022, published Aug 3, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls